MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Triple Helix _ Translation, Commercialization, Technology Transfer, SBIR/STTR, OTA, NonTraditional / New Business Models
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Massachusetts
Targanta Therapeutics
Parents
*Architects: Infectious Disease _ Bacteriology_Antibiotics
*Industry: Massachusetts
*Portfolio Companies: Radius
Companies: Acquired_(M&A)
Finance & Acquisitions: The Medicines Company
Children
Cambridge, Massachusetts
Targanta’s lead product candidate was oritavancin, a novel, semi-synthetic glycopeptide antibiotic being developed to treat serious Gram-positive infections in the hospital and other institutional settings.